Sqz Biotechnologies Co. (SQZ)

Trade SQZ now with
2/1/2022 6:56:06 AM SQZ Publishes Research On SQZ APC' Ability To Overcome Barrier To Effective & Efficient Killer T-Cell Activation
1/24/2022 6:55:32 AM SQZ : FDA Clears IND Application For SQZ-eAPC-HPV, MRNA-based Cell Therapy For Treatment Of HPV16 Positive Solid Tumors
12/9/2021 6:17:22 AM SQZ Biotechnologies Presents Results From Phase 1/2 Trial Of APC Therapy Candidate In HPV+ Solid Tumors At ESMO-IO
10/29/2021 4:56:47 AM SQZ Biotech At A Glance
9/13/2021 6:51:26 AM SQZ Biotechnologies Announces First Autoimmune Disease Indication For Tolerizing Antigen Carrier Platform
6/23/2021 6:49:40 AM SQZ Biotechnologies Presents Regenerative Medicine Data At International Society For Stem Cell Research Annual Meeting
6/9/2021 6:52:18 AM SQZ Biotechnologies Presents Preclinical Results From Tolerizing Antigen Carrier Program
3/18/2021 7:21:32 AM SQZ Biotechnologies FY Net Loss $50.6 Mln Vs $32.2 Mln Last Year
2/12/2021 6:52:56 AM SQZ Biotech Prices Public Offering Of 3 Mln Shares At $20/Shr
2/1/2021 6:49:13 AM SQZ Announces FDA Clearance Of IND Application To Allow For Clinical Trial With SQZ Activating Antigen Carriers